Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) Net Income towards Common Stockholders (2016 - 2026)

Cannabis Suisse has reported Net Income towards Common Stockholders over the past 11 years, most recently at $26908.0 for Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 8.83% to $26908.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $107574.0 through Feb 2026, up 107.17% year-over-year, with the annual reading at -$456142.0 for FY2025, 61.56% up from the prior year.
  • Net Income towards Common Stockholders was $26908.0 for Q1 2026 at Cannabis Suisse, up from $22392.0 in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $57792.0 in Q2 2022 and troughed at -$999085.0 in Q2 2024.
  • The 5-year median for Net Income towards Common Stockholders is -$42854.0 (2022), against an average of -$112715.1.
  • Year-over-year, Net Income towards Common Stockholders crashed 1386.38% in 2024 and then skyrocketed 342.35% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$30050.0 in 2022, then plummeted by 82.35% to -$54797.0 in 2023, then skyrocketed by 109.24% to $5062.0 in 2024, then skyrocketed by 342.35% to $22392.0 in 2025, then increased by 20.17% to $26908.0 in 2026.
  • Per Business Quant, the three most recent readings for CSUI's Net Income towards Common Stockholders are $26908.0 (Q1 2026), $22392.0 (Q4 2025), and $13907.0 (Q3 2025).